利用跨诊断精神疾病遗传易感性解析神经性厌食症的临床结局
本研究在4028例神经性厌食症(AN)患者中,采用基因组结构方程模型提取共享及特质特异性遗传成分并计算多基因风险评分(PRS),分析其与1997-2018年瑞典登记库中临床结局的关联。结果显示,共享精神疾病遗传易感性(PRSshared)每增加1个标准差与疾病负担和精神共病风险增加9-39%相关,而AN特异性遗传易感性(PRSAN-specific)与多数临床结局无统计学显著关联。
要点
- 共享精神疾病遗传易感性(PRSshared)每增加1个标准差,AN患者疾病负担和精神共病风险增加9-39%。
- AN特异性遗传易感性(PRSAN-specific)与多数临床结局无统计学显著关联。
- 重度抑郁症特异性遗传易感性(PRSMDD-specific)每增加1个标准差,AN疾病负担风险增加3-29%。
核心结论
- 共享精神疾病遗传易感性与更差的AN临床结局相关,而AN特异性遗传易感性不是其临床病程的良好指标。
研究设计与样本
- 研究纳入来自Anorexia Nervosa Genetics Initiative(ANGI)并链接瑞典国家登记库的4028例AN患者,平均出生年份1985年(标准差9),3947例(98.0%)为女性。
- 拟合基因组结构方程模型从AN及与其高度遗传相关的精神疾病(强迫症状[OCS]、重度抑郁症[MDD]、精神分裂症[SCZ]和焦虑障碍[ANX])的全基因组关联数据中提取1个共享和5个特质特异性遗传成分并计算相应PRS。
- 分析上述PRS与1997-2018年间报告的临床结局(累积疾病负担、精神共病风险及AN症状学)的关联。
主要发现
- 在AN患者中,PRSshared每增加1个标准差与疾病负担和精神共病风险增加9-39%相关。
- PRSAN-specific与多数临床结局的关联无统计学显著性。
- PRSMDD-specific每增加1个标准差与AN疾病负担风险增加3-29%相关。
临床怎么用
- 共享精神疾病遗传易感性(PRSshared)可能有助于识别AN临床结局更差的高风险患者,为个性化治疗提供参考。
- AN特异性遗传易感性(PRSAN-specific)不宜作为预测AN临床病程的指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Anorexia nervosa (AN) has extensive genetic correlations with other psychiatric disorders, and genetic risk for different psychiatric disorders was associated with distinct clinical courses in AN. Uncovering associations between transdiagnostic psychiatric genetic liability and AN outcomes can facilitate its personalized treatment. In this study, we investigated the associations between transdiagnostic psychiatric genetic liability and outcomes of AN. Genomic structural equation models were fitted to genome-wide association data for AN and psychiatric disorders with high genetic correlations with AN (obsessive-compulsive symptoms [OCS], major depressive disorder [MDD], schizophrenia, and anxiety disorders) to extract one shared and five trait-specific genetic components. Next, we calculated the polygenic risk scores (PRS) for these components, including PRSshared, PRSAN-specific, PRSOCS-specific, PRSMDD-specific, PRSSCZ-specific and PRSANX-specific, which index the shared genetic liability to all five psychiatric traits, and genetic liability specific to AN, OCS, MDD, SCZ and ANX, respectively. We then tested associations between these PRSs and clinical outcomes reported between 1997 and 2018 among AN cases from the Anorexia Nervosa Genetics Initiative (ANGI), linked to Swedish National Registers. The clinical outcomes included cumulative disease burden (i.e., number of diagnoses, medication prescriptions, and inpatient days), risks of psychiatric comorbidities, and AN symptomatology. Among 4028 included AN cases, the mean (SD) birth year was 1985 (9), and 3947 (98.0%) were female. Within AN, +1 SD increase of PRSshared was associated with 9-39% excess risk of disease burden and psychiatric comorbidity, whereas the associations between PRSAN-specific and most clinical outcomes were statistically non-significant. +1 SD increase of PRSMDD-specific was associated with 3-29% increased risk of AN disease burden. Our findings show that shared psychiatric liability is associated with more adverse AN outcomes, whereas AN-specific liability is not a good indicator for its clinical course. This study provides a novel perspective on factors influencing heterogeneity in AN clinical course.
引用
- Lu ZA, Ploner A, Birgegård A, et al. Leveraging transdiagnostic genetic liability to psychiatric disorders to dissect clinical outcomes of anorexia nervosa. Mol Psychiatry. 2025. PMID: 40983652. doi:10.1038/s41380-025-03264-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。